Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/25/19 → 12/31/22 |
Funding
- Covance Inc. ((OE) Prot #APL2-304 // (OE) Prot #APL2-304)
- Apellis Pharmaceuticals, Inc. ((OE) Prot #APL2-304 // (OE) Prot #APL2-304)
Prot #APL2-304: A Phase III, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Sham Injections in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Deg
- Lyon, A (PD/PI)
Project: Research project